Clinical Trials Logo
  1. Home
  2. Hepatocarcinoma
  3. NCT02519075

11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE

Hepatocarcinoma Clinical Trial

Official title:
Diagnostic and Prognostic Role of 11C-Choline PET/CT and DWI MRI for Response Assessment in Patients Affected by Hepatocellular Carcinoma (HCC) and Candidate to TARE

Clinical Trial Summary

Prospective exploratory study specifically investigating the diagnostic and predictive role of 11C-Choline PET/CT and DWI MRI for response assessment in patients affected by HCC and candidate to TARE. A minimum number of 20 patients will be considered for the analysis.

Clinical Trial Description

For the study, all patients with a histological diagnosis of HCC and eligible for TARE, i.e. with liver predominant disease who are not eligible for curative surgery, after multidisciplinary discussion will be included. In all cases, patients will undergo 11C-Choline PET/CT and DWI MRI before starting radioembolization and will be subsequently restaged 3 months after treatment completion. A minimum number of 20 patients will be considered for the analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02519075
Study type Observational
Source Istituto Clinico Humanitas
Contact
Status Completed
Phase
Start date April 2015
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06041490 - Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation Phase 2
Terminated NCT03956940 - Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib N/A
Completed NCT03382327 - Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas N/A
Recruiting NCT03755739 - Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors Phase 2/Phase 3
Recruiting NCT06028724 - A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
Not yet recruiting NCT03718078 - Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery N/A
Recruiting NCT05794048 - METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors N/A
Recruiting NCT04435977 - Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma Phase 2
Completed NCT04811898 - A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment Phase 1
Recruiting NCT05311319 - HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection Phase 2
Completed NCT05464706 - Study on the Quality of Life (QoL) After Liver Surgery N/A
Completed NCT01411579 - Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma N/A
Recruiting NCT03356236 - Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation